Want to join the conversation?
$CAMP expects 2Q17 revenue of $90-95MM and adjusted EPS of $0.25-0.31. GAAP results of operations is expected to be between loss of $0.02 per share and EPS of $0.02. Adjusted EBITDA is anticipated to be in $12-16MM range. The outlook includes about $6MM of revenue and modest positive contribution to profitability from Satellite segment.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?